[1]
“Lipid–Polymer Hybrid Nanoparticles for Depression Therapy: A Novel Strategy for Enhanced Brain Drug Delivery”, JDDB, vol. 2, no. 2, pp. 17–24, Jul. 2025, doi: 10.61920/tqfc1w78.